The board of directors of healthcare company Eli Lilly and Company (NYSE:LLY) declared a dividend of USD0.5625 per share on the company's outstanding common stock for the the third 2018, it announced on on Monday.

This cash dividend is due on 10 September 2018 to shareholders of record at the close of business as of 15 August 2018.

Eli Lilly and Company said it is committed to creating high-quality medicines that meet real needs and remains true to its mission.

Across the globe, the company's employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease as well as give back to communities through philanthropy and volunteerism.